Literature DB >> 20520290

Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level.

Halldóra Jónsdóttir1, Stein Opjordsmoen, Astrid B Birkenaes, John A Engh, Petter Andreas Ringen, Anja Vaskinn, Trond O Aamo, Svein Friis, Ole A Andreassen.   

Abstract

Medication nonadherence in severe mental disorders is an important clinical issue, but estimates vary between studies. There is a need for valid self-reports for both research and clinical practice. This study examined the level of adherence to prescribed medication in outpatients with severe mental disorders and evaluated the validity of a simple self-report rating of adherence. From an ongoing study of severe mental disorders, 280 patients with schizophrenia and bipolar disorder who were prescribed psychopharmacological agents were included. We assessed adherence with serum concentration of medicines and tested the sensitivity and specificity of a simple self-report questionnaire for patients and compared with a report from health personnel. Adherence rate defined by serum concentrations within reference level was 61.6% in the total sample, 58.4% for schizophrenia and 66.3% for bipolar disorder. The patients' self-report scores overestimated adherence, but correlated significantly to health personnel scores (r = 0.50) and to serum concentration of medication (r = 0.52); the positive predictive value was 70%, and the negative predictive value was 91%. In this naturalistic sample, outpatients with severe mental disorders showed relatively good adherence to prescribed medication, and self-report questionnaires seem to be a valid method for measuring adherence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20520290     DOI: 10.1097/JCP.0b013e3181d2191e

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  35 in total

Review 1.  Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review.

Authors:  Jennifer B Levin; Anna Krivenko; Molly Howland; Rebecca Schlachet; Martha Sajatovic
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

2.  Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies.

Authors:  John M Kane; Taishiro Kishimoto; Christoph U Correll
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

3.  "Will I need to take these medications for the rest of my life?"

Authors:  Stephen R Marder; Michael F Zito
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

4.  Predictors of medication adherence among patients with severe psychiatric disorders: findings from the baseline assessment of a randomized controlled trial (Tecla).

Authors:  Ulrike Stentzel; Neeltje van den Berg; Lara N Schulze; Thea Schwaneberg; Franziska Radicke; Jens M Langosch; Harald J Freyberger; Wolfgang Hoffmann; Hans-Jörgen Grabe
Journal:  BMC Psychiatry       Date:  2018-05-29       Impact factor: 3.630

Review 5.  What are validated self-report adherence scales really measuring?: a systematic review.

Authors:  Thi-My-Uyen Nguyen; Adam La Caze; Neil Cottrell
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

6.  Medication Adherence Among Adolescents with Bipolar Disorder.

Authors:  Tina R Goldstein; Megan Krantz; John Merranko; Matthew Garcia; Loren Sobel; Carlos Rodriguez; Antoine Douaihy; David Axelson; Boris Birmaher
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-07-15       Impact factor: 2.576

7.  Factors associated with the effectiveness of a telephone-based nursing strategy for enhancing medication adherence in schizophrenia.

Authors:  José Manuel Montes; Jorge Maurino; Teresa Diez; Jerónimo Saiz-Ruiz
Journal:  Clin Pract Epidemiol Ment Health       Date:  2011-06-09

8.  Psychotropic medicine beliefs, side effects and adherence in schizophrenia: a patient-caregiver dyad perspective.

Authors:  Irene A Kretchy; Bernard Appiah; Kofi Agyabeng; Emmanuel M Kwarteng; Enyonam Ganyaglo; Grace Owusu Aboagye
Journal:  Int J Clin Pharm       Date:  2021-04-09

9.  Psychotropic medication in geriatric psychiatric patients: use and unreported use in relation to serum concentrations.

Authors:  Marit Tveito; Jørgen G Bramness; Knut Engedal; Bernhard Lorentzen; Helge Refsum; Gudrun Høiseth
Journal:  Eur J Clin Pharmacol       Date:  2014-07-18       Impact factor: 2.953

Review 10.  Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

Authors:  Oliver D Howes; Rob McCutcheon; Ofer Agid; Andrea de Bartolomeis; Nico J M van Beveren; Michael L Birnbaum; Michael A P Bloomfield; Rodrigo A Bressan; Robert W Buchanan; William T Carpenter; David J Castle; Leslie Citrome; Zafiris J Daskalakis; Michael Davidson; Richard J Drake; Serdar Dursun; Bjørn H Ebdrup; Helio Elkis; Peter Falkai; W Wolfgang Fleischacker; Ary Gadelha; Fiona Gaughran; Birte Y Glenthøj; Ariel Graff-Guerrero; Jaime E C Hallak; William G Honer; James Kennedy; Bruce J Kinon; Stephen M Lawrie; Jimmy Lee; F Markus Leweke; James H MacCabe; Carolyn B McNabb; Herbert Meltzer; Hans-Jürgen Möller; Shinchiro Nakajima; Christos Pantelis; Tiago Reis Marques; Gary Remington; Susan L Rossell; Bruce R Russell; Cynthia O Siu; Takefumi Suzuki; Iris E Sommer; David Taylor; Neil Thomas; Alp Üçok; Daniel Umbricht; James T R Walters; John Kane; Christoph U Correll
Journal:  Am J Psychiatry       Date:  2016-12-06       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.